Ohne eingeschaltetes JavaScript können Sie PSIAC nicht in vollem Umfang nutzen.
Literaturverzeichnis
Xie RQ. Int J Cardiol. Apr 2010; 140(2): 255-7
Pubmed [8419]
Xie Y. Nat Med. Jan 2025
Pubmed [13921]
Ximenez JPB. BMC Pharmacol Toxicol. Dec 2019; 20(Suppl 1): 81
Pubmed , Volltext , DOI [10513]
Xin H. Aliment Pharmacol Ther. May 2005; 21(9): 1105-9
Pubmed [4088]
Xiong GL. J Clin Psychopharmacol. Aug 2008; 28(4): 472-3
Pubmed [2001]
Xu BB. Pharmazie. Jan 2014; 69(1): 43-7
Pubmed [4383]
Xu H. Chirality. Mar 2007; 19(3): 163-70
Pubmed [7447]
Xu H. Conn Med. Sep 2001; 65(9): 527-9
Pubmed [5813]
Xu M. Pharmacotherapy. Mar 2021; 41(3): 277-290
Pubmed [11608]
Xu Q. Front Cell Dev Biol. Jul 2020; 8: 454
Pubmed [11383]
Xu R. Eur J Clin Pharmacol. Jun 2018; 74(6): 755-765
Pubmed [5125]
Xu RA. Pharmazie. May 2013; 68(5): 365-8
Pubmed [353]
Xu WJ. Neuropsychiatr Dis Treat. Apr 2016; 12: 781-3
Pubmed [11605]
Xu Y. CNS Drugs. May 2019; 33(5): 513-522
Pubmed [13527]
Xu ZH. Br J Clin Pharmacol. Sep 1999; 48(3): 416-23
Pubmed [13706]
Xue FS. Anesth Analg. Jun 1998; 86(6): 1322-7
Pubmed [7570]
Xue W. Clin Pharmacol Drug Dev. Nov 2021; 10(11): 1316-1324
Pubmed [12179]
Yabuki Y. Pharmacology. Jan 2017; 99(3-4): 160-171
Pubmed [9927]
Yafi FA. Sex Med Rev. Apr 2018; 6(2): 242-252
Pubmed [7644]
Yagi T. Br J Clin Pharmacol. Feb 2023; 89(2): 887-897
Pubmed [12769]
Yagi T. Drug Metab Pharmacokinet. Jan 2012; 27(2): 248-54
Pubmed [13030]
Yagi Y. Toxicol Appl Pharmacol. Nov 2014; 281(1): 39-47
Pubmed [10890]
Yakiwchuk EM. Ann Pharmacother. May 2008; 42(5): 698-703
Pubmed [6426]
Yamada A. Pharmacogenet Genomics. Sep 2011; 21(9): 523-30
Pubmed [12101]
Yamada K. J Clin Psychopharmacol. Aug 2005; 25(4): 398-9
Pubmed [13657]
Yamada S. Drug Metab Dispos. Aug 2010; 38(8): 1314-21
Pubmed [348]
Yamada S. Ther Drug Monit. Dec 2009; 31(6): 764-8
Pubmed [2975]
Yamaguchi H. Eur J Pediatr. Dec 2014; 173(12): 1631-4
Pubmed [4876]
Yamaguchi T. J Smooth Muscle Res. Oct 2005; 41(5): 247-56
Pubmed [5073]
Yamama Y. Life Sci. Oct 2010; 87(17-18): 565-71
Pubmed [9729]
Yamamoto F. Jpn J Antibiot. Feb 2004; 57(1): 124-33
Pubmed [6040]
Yamamoto K. Ann Pharmacother. Oct 1997; 31(10): 1261-2
Pubmed [5234]
Yamamoto T. Proc Soc Exp Biol Med. Dec 2000; 225(3): 200-6
Pubmed [5057]
Yamamoto T. Xenobiotica. Aug 2003; 33(8): 823-39
Pubmed [32]
Yamamoto Y. Drug Metab Pharmacokinet. Jun 2015; 30(3): 214-20
Pubmed [9254]
Yamamoto Y. Epilepsy Behav. May 2014; 34: 124-6
Pubmed [9292]
Yamamoto Y. Eur J Clin Pharmacol. Oct 2014; 70(10): 1203-10
Pubmed [9424]
Yamamoto Y. Jpn J Infect Dis. Dec 2000; 53(6): 244-5
Pubmed [7102]
Yamamoto Y. Ther Drug Monit. Apr 2015; 37(2): 229-35
Pubmed [9298]
Yamamoto Y. Ther Drug Monit. Feb 2017; 39(1): 55-61
Pubmed [9407]
Yamamoto Y. Ther Drug Monit. Jun 2013; 35(3): 305-12
Pubmed [9435]
Yamanaka K. J Pharm Sci. Nov 1996; 85(11): 1234-7
Pubmed [13238]
Yamaori S. Biochem Pharmacol. Jun 2010; 79(11): 1691-8
Pubmed [7508]
Yamaori S. Drug Metab Dispos. Nov 2011; 39(11): 2049-56
Pubmed [7510]
Yamaori S. Life Sci. Apr 2011; 88(15-16): 730-6
Pubmed [7516]
Yamaori S. Life Sci. Sep 2015; 136: 87-93
Pubmed [7565]
Yamashita S. Pharmacology. Jun 1997; 54(6): 319-27
Pubmed [9436]
Yamaya M. Nihon Kokyuki Gakkai Zasshi. Jan 2002; 40(1): 3-10
Pubmed [3794]
Yamazaki H. Chem Res Toxicol. Jun 1998; 11(6): 659-65
Pubmed [4673]
Yamazaki H. Drug Metab Dispos. Jun 2001; 29(6): 794-7
Pubmed [11990]
Yamazaki H. Drug Metab Dispos. Nov 1998; 26(11): 1053-7
Pubmed [434]
Yamazaki S. Drug Metab Dispos. Aug 2018; 46(8): 1200-1211
Pubmed [7221]
Yamazaki T. Clin Pharmacol Drug Dev. Jan 2017; 6(1): 66-75
Pubmed , Volltext , DOI [7617]
Yamreudeewong W. Drug Saf. Jan 2003; 26(6): 421-38
Pubmed [4570]
Yan JH. J Clin Pharmacol. Nov 2006; 46(11): 1250-8
Pubmed [3444]
Yan KH. Oncol Rep. Sep 2013; 30(3): 1497-505
Pubmed [3955]
Yang BB. Clin Pharmacokinet. May 2011; 50(5): 295-306
Pubmed [12994]
Yang C-H et al. Medicine 95: e2930, No. 9. Mar 2016
Pubmed [10166]
Yang FW. Gen Hosp Psychiatry. May 2011; 33(3): 302.e1-2
Pubmed [2242]
Yang FW. J Clin Psychopharmacol. Apr 2011; 31(2): 245-6
Pubmed [9968]
Yang J. Curr Opin Pharmacol. Apr 2016; 27: 78-85
Pubmed [10579]
Yang TJ. Drug Metab Dispos. Jan 1999; 27(1): 102-9
Pubmed [109]
Yang X. Medicine (Baltimore). Mar 2019; 98(12): e14908
Pubmed [11738]
Yang Y. Expert Rev Clin Pharmacol. Feb 2020; 13(2): 135-146
Pubmed [12329]
Yang YC. Aust N Z J Psychiatry. Feb 2019; 53(2): 175-176
Pubmed [7989]
Yang YF. Br J Pharmacol. Dec 2021; 178(24): 4808-4825
Pubmed [11670]
Yano R. Ann Pharmacother. Mar 2009; 43(3): 453-8
Pubmed [6055]
Yao C. J Clin Pharmacol. May 2005; 45(5): 519-28
Pubmed [2998]
Yao M. Biomed Chromatogr. Jul 2009; 23(7): 677-91
Pubmed [8078]
Yao R. Psychiatry Res. Feb 2020; 284: 112750
Pubmed [11515]
Yao Y. Eur J Med Chem. Feb 2009; 44(2): 854-61
Pubmed [9024]
Yap et al. Eur J Cancer Care (Engl). 2009 Dec 17 [3141]
Yap KY. Clin Ther. Aug 2008; 30(8): 1385-407
Pubmed [8330]
Yapa HM. J Acquir Immune Defic Syndr. Jun 2016; 72(2): 138-52
Pubmed [6479]
Yarman S. Neuro Endocrinol Lett. Jan 2012; 33(3): 340-6
Pubmed [10950]
Yaryura-Tobias JA, Wolpert A, Dona L, Merlis S. Action of L-dopa in drug-induced extrapyramidalism. Dis Nerv Syst (1970) 1, 60-3 [880]
Yaryura-Tobias JA. Dis Nerv Syst. Jan 1970; 31(1): 60-3
Pubmed [1447]
Yassa R. A case of lithium-chlorpromazine intraction. J Clin Psychiatry (1986) 47, 90-1 [887]
Yassini M. Iran J Pharm Res. Oct 2014; 13(4): 1227-33
Pubmed , Volltext [10302]
Yasuda K. J Pharmacol Exp Ther. Oct 2002; 303(1): 323-32
Pubmed [8234]
Yasuhara M. J Pharmacobiodyn. Nov 1990; 13(11): 681-7
Pubmed [4183]
Yasui N, Otani K, Kaneko S, Ohkubo T, Osani T, Ishida M, Mihara K, Kondo T, Sugawara K, Fukushima Y. Inhibition of Trazodone metabolism by thioridazine in humans. Ther Drug Monit (1995) 17, 333-5 [2076]
Yasui N. Int Clin Psychopharmacol. Jul 1997; 12(4): 225-9
Pubmed [724]
Yasui N. Kobe J Med Sci. Feb 2011; 56(5): E214-9
Pubmed [8316]
Yasui N. Psychopharmacology (Berl). Jun 2000; 150(2): 185-90
Pubmed [3184]
Yasui N. Psychopharmacology (Berl). Oct 1998; 139(3): 269-73
Pubmed [31]
Bildrechte: © spinetta / Fotolia